IgE-binding proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus

Citation
Ka. Brander et al., IgE-binding proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus, J ALLERG CL, 104(3), 1999, pp. 630-636
Citations number
24
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
ISSN journal
00916749 → ACNP
Volume
104
Issue
3
Year of publication
1999
Part
1
Pages
630 - 636
Database
ISI
SICI code
0091-6749(199909)104:3<630:IPRAST>2.0.ZU;2-6
Abstract
Background: Basidiomycetes spores are ubiquitously distributed, found throu ghout the year in outdoor and indoor air, and represent relevant sources of aeroallergens associated with allergy and asthma, Objective: Cloning and characterization of Coprinus comatus (shaggy cap mus hroom) allergens is essential to elucidate their molecular characteristics and to improve the diagnosis of allergy, Methods: A complementary DNA (cDNA) library of C comatus displayed on phage surface was screened with sera of basidiomycete-sensitized individuals. Su bcloning and high-level expression of one of the enriched cDNAs allowed the isolation of a [His](6)-tagged recombinant protein formally termed rCop c 1. The allergenic properties of rCop c 1 were investigated in vitro by ELIS A, inhibition experiments, immunoblots, and proliferation assays and in viv o by skin tests. Results: The rCop c 1-encoding cDNA spans 435 bp and contains an open readi ng frame of 246 bp, predicting a protein of 8.96 kd without significant seq uence homology to known proteins, Immunoblots with [His](6)-rCop c 1 fusion protein show a background free IgE-binding band of the expected size that can be completely inhibited by crude C comatus extracts in ELISA, rCop c 1 induced specific proliferative responses in PBMCs of C comatus-sensitized i ndividuals. The incidence of sensitization to rCop c 1 among 92 sera of bas idiomycete-sensitized individuals tested in ELISA was 25%, indicating that Cop c 1 is an intermediate allergen. However, prick tests showed that less than 2 pmol of the rCop c 1 protein was able to induce strong specific skin reactions in sensitized individuals. Conclusions: rCop c 1, the first cloned allergen from the genus Coprinus, f ulfills all the criteria required to be classified as a clinically relevant allergen. The data demonstrate at the molecular level the presence of sens itizing molecules among Basidiomycetes, the most important source contribut ing to the total spore load in the outdoor air.